Roche warns of counterfeit vials of best-selling cancer drug Avastin

Roche has issued warnings about counterfeit vials of Avastin. You can read the article here.
A major concern of a number of people I speak with in Pharma is that this sort of issue with counterfeit drugs will only get worse.
According to the article:
"Recent legislation introduced in the House would give the FDA greater resources and authority to inspect foreign drug imports. Separate legislation would create a mandatory barcode system to monitor the authenticity of all prescription drugs moving through the U.S. supply chain."
But the question is - Are these measures going to be enough?